A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
University of California, Davis
University of California, Davis
Brigham and Women's Hospital
ViroMissile, Inc.
University of Florida
Institut du Cancer de Montpellier - Val d'Aurelle
Hospices Civils de Lyon
University of Nebraska
Guerbet
Mayo Clinic
Tanabe Pharma America, Inc.
BioXcel Therapeutics Inc
Fudan University
Jonsson Comprehensive Cancer Center
Jagiellonian University
University of Utah
Travera Inc
RECORDATI GROUP
Charite University, Berlin, Germany
Medical College of Wisconsin
Georgetown University
The Affiliated Hospital of Qingdao University
Ciusss de L'Est de l'Île de Montréal
Xencor, Inc.
Medical College of Wisconsin
British Columbia Cancer Agency
SpeciCare
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
SWOG Cancer Research Network
University of Southern California
UNC Lineberger Comprehensive Cancer Center
Stanford University
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Rutgers, The State University of New Jersey